Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark N Kirstein

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
Topoisomerase I interactive agentsMark N Kirstein, P Kellie Turner, Clinton F Stewart
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Review of selected patents for cancer therapy targeting tumor angiogenesisMark N Kirstein, Megan M Moore, Arkadiusz Z Dudek
Expert Opinion on Therapeutic Targets|July 30, 2003
Molecular targets in the inhibition of angiogenesisArkadiusz Z Dudek, Wojciech Z Pawlak, Mark N Kirstein
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 15, 2002
New liquid chromatographic assay with electrochemical detection for the measurement of amifostine and WR1065Feng Bai, Mark N Kirstein, Suzan K Hanna, et al.
British Journal of Clinical Pharmacology|April 30, 2016
Pharmacokinetic-pharmacodynamic modelling of acute N-terminal pro B-type natriuretic peptide after doxorubicin infusion in breast cancerShuang Liang, Richard C Brundage, Pamala A Jacobson, et al.
Chemmedchem|February 1, 2011
Combinatorial pharmacologic effects of gemcitabine and its metabolite dFdUAlexey Benyumov, Vadim J Gurvich, Lev G Lis, et al.
American Journal of Clinical Oncology|December 4, 2010
Phase 1 trial of gemcitabine with bortezomib in elderly patients with advanced solid tumorsSatya V Bommakanti, Arkadiusz Z Dudek, Amit Khatri, et al.
Mathematical Biosciences|October 7, 2003
A mechanistic mathematical model of temozolomide myelosuppression in children with high-grade gliomasJohn Carl Panetta, Mark N Kirstein, A J Gajjar, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 31, 2002
Determination of plasma topotecan and its metabolite N-desmethyl topotecan as both lactone and total form by reversed-phase liquid chromatography with fluorescence detectionFeng Bai, Mark N Kirstein, Suzan K Hanna, et al.
The AAPS Journal|November 22, 2011
Pharmacodynamic modeling of sequence-dependent antitumor activity of insulin-like growth factor blockade and gemcitabineAmit Khatri, Richard C Brundage, Jessica M Hull, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Cancer Chemotherapy and Biological Response Modifiers|April 22, 2003
Topoisomerase I interactive agentsMark N Kirstein, P Kellie Turner, Clinton F Stewart
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Review of selected patents for cancer therapy targeting tumor angiogenesisMark N Kirstein, Megan M Moore, Arkadiusz Z Dudek
Expert Opinion on Therapeutic Targets|July 30, 2003
Molecular targets in the inhibition of angiogenesisArkadiusz Z Dudek, Wojciech Z Pawlak, Mark N Kirstein
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|May 15, 2002
New liquid chromatographic assay with electrochemical detection for the measurement of amifostine and WR1065Feng Bai, Mark N Kirstein, Suzan K Hanna, et al.
British Journal of Clinical Pharmacology|April 30, 2016
Pharmacokinetic-pharmacodynamic modelling of acute N-terminal pro B-type natriuretic peptide after doxorubicin infusion in breast cancerShuang Liang, Richard C Brundage, Pamala A Jacobson, et al.
Chemmedchem|February 1, 2011
Combinatorial pharmacologic effects of gemcitabine and its metabolite dFdUAlexey Benyumov, Vadim J Gurvich, Lev G Lis, et al.
American Journal of Clinical Oncology|December 4, 2010
Phase 1 trial of gemcitabine with bortezomib in elderly patients with advanced solid tumorsSatya V Bommakanti, Arkadiusz Z Dudek, Amit Khatri, et al.
Mathematical Biosciences|October 7, 2003
A mechanistic mathematical model of temozolomide myelosuppression in children with high-grade gliomasJohn Carl Panetta, Mark N Kirstein, A J Gajjar, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 31, 2002
Determination of plasma topotecan and its metabolite N-desmethyl topotecan as both lactone and total form by reversed-phase liquid chromatography with fluorescence detectionFeng Bai, Mark N Kirstein, Suzan K Hanna, et al.
The AAPS Journal|November 22, 2011
Pharmacodynamic modeling of sequence-dependent antitumor activity of insulin-like growth factor blockade and gemcitabineAmit Khatri, Richard C Brundage, Jessica M Hull, et al.
Pageof 4